Monitoring symptoms with an app in IDH-mutated glioma
Part of Cancer clinical trials.
This study tests a smartphone app called Resilience PRO that helps you track your symptoms and quality of life during treatment for IDH-mutated glioma. It is designed to help doctors monitor how you are doing and manage side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a grade 2, 3, or 4 glioma that has an IDH1 or IDH2 mutation.
- You are about to start a new treatment for your glioma, such as chemotherapy or targeted therapy.
- You are willing to use a smartphone app to track your symptoms and quality of life.
- You have health insurance (social security coverage).
- You do not have severe language problems or memory issues that would make it hard to use the app.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a smartphone app can help patients or caregivers perform a neurological exam at home. It aims to make check-ups easier for people with brain tumors.
This study tests a digital platform that helps you manage your glioma treatment at home. It aims to make it easier to follow your treatment plan and stay connected with your care team.
This study asks patients with a specific type of low-grade brain tumor (IDH mutant grade 2 glioma) to share their experiences and quality of life while receiving a treatment called vorasidenib, with or without radiation. Your feedback helps doctors understand how well the treatment works from your perspective.
This trial tests whether using a smartphone app to report symptoms helps patients feel better and manage side effects during cancer treatment. If you have cancer at any stage and are on systemic therapy, you may be able to join.
This study offers cognitive rehabilitation and long-term monitoring for adults with lower grade gliomas. It aims to help improve thinking and memory problems you may be experiencing.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.